Learn More
Medchemexpress LLC Ivarmacitinib | 1445987-21-2 | MFCD32701909 | 99.6% | 414.48 g/mol | C18H22N8O2S | 5 MG

Supplier: Medchemexpress LLC HY1127245MG
Ivarmacitinib is a selective Janus kinase 1 (JAK1) inhibitor supplied as a small-molecule powder for research use. It inhibits JAK1-mediated STAT3 phosphorylation, induces apoptosis in target cells, and exhibits anti-proliferative and anti-inflammatory activity. The compound is intended for in vitro and preclinical studies probing JAK/STAT signaling and related immuno-inflammatory pathways.
- Selective inhibition of JAK1-mediated signaling.
- Demonstrated inhibition of STAT3 phosphorylation.
- Supports studies of apoptosis, inflammation, and cell proliferation.
- Available as a stable powder suitable for low-temperature storage.
- Molecular weight 414.48 g/mol; formula C18H22N8O2S for reference.
- Provided in small milligram quantities for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.